Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001894562-25-000024
Filing Date
2025-05-19
Accepted
2025-05-19 19:45:33
Documents
3
Period of Report
2025-05-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1747698326.html 4  
1 FORM 4 wk-form4_1747698326.xml 4 4177
2 EX-24 prime_medicinex-xpowerxo.htm EX-24 5168
3 prime_medicinex-xpowerxo001.jpg GRAPHIC 309131
  Complete submission text file 0001894562-25-000024.txt   436643
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address
Marrazzo Jeffrey D (Reporting) CIK: 0001631262 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41536 | Film No.: 25965797

Mailing Address 60 FIRST ST. CAMBRIDGE MA 02141
Business Address 60 FIRST ST. CAMBRIDGE MA 02141 617-465-0013
Prime Medicine, Inc. (Issuer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)